Share Name Share Symbol Market Type Share ISIN Share Description
Scancell Holdings Plc LSE:SCLP London Ordinary Share GB00B63D3314 ORD 0.1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 6.40 123,756 07:47:28
Bid Price Offer Price High Price Low Price Open Price
6.20 6.60 6.40 6.40 6.40
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -6.71 -1.45 30
Last Trade Time Trade Type Trade Size Trade Price Currency
12:05:45 O 100,000 6.46 GBX

Scancell (SCLP) Latest News

More Scancell News
Scancell Takeover Rumours

Scancell (SCLP) Share Charts

1 Year Scancell Chart

1 Year Scancell Chart

1 Month Scancell Chart

1 Month Scancell Chart

Intraday Scancell Chart

Intraday Scancell Chart

Scancell (SCLP) Discussions and Chat

Scancell Forums and Chat

Date Time Title Posts
15/10/201909:20Using immunology to fight cancer.25,788
13/6/201918:12Could this be the end of cancer?771
20/5/201817:25Scancell short thread2
22/8/201608:20Question11
16/8/201408:47Using immunology to fight cancer (LTH W/O Rose Tints - Free Speech Thread)161

Add a New Thread

Scancell (SCLP) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2019-10-15 11:05:476.46100,0006,460.00O
2019-10-15 07:54:016.2323,7561,478.81O
View all Scancell trades in real-time

Scancell (SCLP) Top Chat Posts

DateSubject
15/10/2019
09:20
Scancell Daily Update: Scancell Holdings Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker SCLP. The last closing price for Scancell was 6.40p.
Scancell Holdings Plc has a 4 week average price of 6.40p and a 12 week average price of 4.54p.
The 1 year high share price is 11p while the 1 year low share price is currently 3.65p.
There are currently 465,355,867 shares in issue and the average daily traded volume is 109,509 shares. The market capitalisation of Scancell Holdings Plc is £29,782,775.49.
04/10/2019
08:26
tosh123: Morning all, i think that by now,everyone finally realises what an idiot he is. He made the £8 prediction over 2 years ago, and it had nothing to do with trials or anything else, it was merely a number plucked from thin air. He has consistently lied and mislead anyone who would listen, and this £8, is just another attempt to lure the unwary into parting with their cash, based on nothing other than his over inflated ego. The truth of the matter is, he hasn't got a clue what he's talking about. Firstly, how can you predict a share price ? It's impossible ! Dilution / warrants / stock splits / share buy backs, the list of possible share price affecting events is endless ... Market cap however, is a different matter, you can try to predict that, but even that is fraught with danger. If the company can finally get their sh1t together ( with the aid of Diggles ) then we could possibly be looking at a market cap of £500 mill in 2 years.... maybe. The prospect of £8 / share, is pure fantasy. Does anyone really think that Vulpes will hold on to their shares at anything over 50p ? Of course they won't, and nor will the other ii's. Should ALL the trials be successful, this will be bought out at a figure way south of £1 bill. The guy is a cheat... simple... believe his nonsense at your peril.
19/9/2019
07:22
terror: Oxford Tech report Scancell, the Company’s only quoted investment, continues to make progress. It has received approval to start the UK Phase 2 melanoma combination trial of SCIB1 and has begun screening potential patients in Nottingham. It has also started the first joint programme on its new AvidiMab anti-glycan antibody technology, having partnered with a large unnamed pharma. AvidiMab antibodies target sugars rather than proteins on the cell surface. Scancell raised £3.9 million through the issue of new shares at 5p per share, a significant discount to previous placings, to Vulpes Life Science Fund in June. The money will support the transition of Modi-1 to the clinic. Vulpes now owns 16.67% of Scancell and Martin Diggle from Vulpes was appointed to the Scancell board, which we believe will increase the chance of a successful outcome for them. The Scancell share price has risen following the Vulpes investment and our investment has been valued at 6.8p, the AIM share price at 31 August. Investment £409,000. Value £349,000
13/9/2019
09:57
panama7: Ivy, yeah it's starnge how all BOD's accept responsibility for a rising share price but never accept responsibility for a falling share price. Goodfellow eve had the nerve to say that a lot of Investors had made a lot of money again how disrespectful when there has been a falling share price for 6 years and anyone who bought after his infamous Frankfurt video couldn't have possibly made any profit.
13/9/2019
09:04
panama7: Gazza, had you been there last year and seen the contempt and arrogance that the BOD displayed to their Investors you would understand why I was not prepared to let them do that again. As for me interrupting RG totally not true, he was interrupting me before I had finished making my point, I did say to him let me finish making my point and then you can answer. At the time JC was calling a halt to Q & A I had moved on from the Goodfellow issue, I think I may have been asking him why when we are told year after year of the great progress being made why it is not reflected in the share price and why year after year when these Investors come back is the share price lower then the year before if they have made such great progress and there is significant interest in the platorms. The bottom line is if a CEO of any Company tells Investors when the share price is 34p that he is going to sell the Company and the share price is below that price for 6 years and Investors have lost thousands he should bloody well be accountable
04/9/2019
12:50
ivyspivey: Wish it was Inanaco who had resigned and stayed away rather than a valued and well liked poster like Lozan. After the hell of a beating Inanaco and his chums in Parliament took last night you think he would be licking his wounds. The question is which will be delayed longer Brexit is the start of the Combo trial. The only thing we do know is Inanaco will get it wrong whether it is him saying that SCLP have NOT delayed the start of the SCIB 1 Combo trial or his original claim that Brexit was nailed on 31st March. Great to see the SCLP share price rise today in spite of the endless lying by likes of Inanaco and his carpetbagger mates of the IRG
25/6/2019
17:17
tosh123: ineptico..... "you have not traded .. that is the point" .... what an absolutely stupid and ludicrous statement... are you really that dense ? How do you think anyone manages to create a free ride ???? You really are a plank. Honestly, every time you post, you just make yourself look more and more stupid ! and then... another pearl of wisdom.... " I just hold for deal ... share price not relevant" Of course the share price is relevant you blithering idiot ! Just how stupid are you ! If your average is 30p and a deal gets done at 5 times today's share price, ( 32p ) which many would take, by the time you've paid costs, you'll be making a penny at best .... you really are very very stupid aren't you. The more you post, the more you show just how little you know about anything... scarily so.
08/3/2019
12:55
inanaco: tosh123 - 02 May 2016 - 14:05:41 - 5333 of 20421 Using immunology to fight cancer. - SCLP Thats nice and easy to sort out... My average is way under the current SP, WHAT IS YOURS ? Is it under the current share price ? nice simple question that will put this one to bed once and for all. And you seem to have overlooked the part of my post about W's bet, once again... surely you need to take him up on his wager after all your posts, because surely you need to prove that you were right, otherwise you'll just continue to look like a muppet. share price 15p .... """ My average is way under the current share price """" so that is one post that you admit .... now considering you are holding for a deal and the share price has hardly moved up from that figure but moved down, and indeed you Did NOT buy in around the 10p lows ..as you told us you would NOT . so who is lying here ... Freebies with an Average or Tosh runs on free shares tosh123 - 28 Apr 2016 - 09:08:56 - 5266 of 20421 Using immunology to fight cancer. - SCLP for the millionth time... i am comfortable as my average is very low ( way under the current share price ) despite a purchase at circa 23p and another at circa 13p, its really not rocket science ! As for declaring my trades, this will never happen you idiot ! I have nothing to prove to you, and the fact that you keep demanding such a stupid thing , only goes to reinforce your arrogance, and total lack of understanding of how things work. Only those with huge ego's feel the need to advertise their holdings and trading activities. Tosh you are just waffle ......... "i am comfortable with my average"
28/2/2019
14:43
gazza: Inan, you said: "Currency movements which are actually inverse to the stock market £/$ pair" OK, let's work this out. If you are talking about SCLP share price then.. Has gone from 60p to 6p Inverse would be 6p to 60p (x 10 up) £/E was 1.00/1.20 so applying your inverse stock price principle 1 GBP would now be 12 EUR. If that were the case, I'd have bought the house next door to Loz and would now be sharing a 1664 whilst discussing the grass length.
14/1/2019
09:43
tosh123: Somewhat ironic that the caped crusader ridicules the holders of VAL by saying that he warned them of the share price collapse , when HE himself was warned by many of us that the SCLP share price was going to crash, but still bought more at 45p. The idiot is pointing a finger at people who have done EXACTLY the same as he is guilty of... What a plank.
13/12/2018
11:46
knowlesi: The share price here has been hammered so hard, the trend is so strong which tells you there are a lot of investors who have given up over the last 5/6 years. The company has failed to progress at a pace that shareholders expected (whether that's shareholder expectation or the company that miscalculated is up for debate) - given the AGM comments I struggle to see anything really changing over the next 12 months re meaningful re-rate news. I don't think your average AIM investor is looking at the market cap and comparing our platform with others and saying there is a disconnect re relative values, rather they are seeing delays, a long risky road ahead and saying no thanks. This is why the share price could half again, in fact probably down is more likely on no news. Owning scancell feels a bit like being an option buyer - every day there is time decay which pulls the value of the option closer to zero - it's like everyday there is no news, more sellers. Probably not surprising considering the large retail holder base here, I have long been critical of the bod for not being more active in increasing their II ownership, which is generally smart money and in theory longer term capital. Your average retail guy doesn't want his money in a risky 5 year play. The bod seemed very clear at the AGM - and I actually agree with them, focusing on the share price is just a distraction for them and they should concentrate on getting IP into clinical trials and managing the business (we really can't have any more delays). Given this and the comments from JC - they see value coming from data and that's 18-24 months away - this therefore presents a you with a timeframe and it's by and large binary on success of clinical trails. Either investors wake up and look at the market cap vs. others and say this is too cheap or Scancell embark on more friendly share holder comms - being more proactive, get out to II's and present and get that institutional anchor base we desparately need - without those two actions (and I think the later is unlikely based on AGM comments) - the downward pressure will persist. Now all this said, I think this is exactly the time to buy - being a contrarian a good indicator of when to buy a stock is when everyone hates it/pessimism is strong. No good news whatsoever is priced in, there are many disgruntled existing holders and ex shareholders nursing losses - holding scancell has been a lesson in the power of sentiment and this seems to override fundamentals in this share (strong retail % ownership) - you can see if from the BB - when there is high fiving and gloating - the share punishes. When there is bickering amongst the bullish regulars - the share price goes on a burn. It's a classic sentiment gauge. Buy when investors hate and sell the stuff that is loved - sentiment become disconnected from the fundamental outlooks in both cases, given that I think it's hard to think of a better time to buy...
Scancell share price data is direct from the London Stock Exchange
Your Recent History
LSE
SCLP
Scancell
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191016 04:37:40